Company overview
Lucid Scientific offers RESIPHER, a cell culture monitoring system that provides continuous, non-invasive measurement of oxygen consumption in standard 96-well plates for life sciences and pharma research. This biotechnology tool accelerates drug discovery and basic biological research by streaming real-time metabolic data via a web app. Headquartered in Atlanta, Georgia, the company manufactures sensitive optical oxygen sensors integrated into sterilized lids for up to four weeks of monitoring.
https://www.lucidscientific.com/ is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include lucid scientific, resipher, cell culture monitor, oxygen consumption sensor, drug discovery tools.
Products and technologies associated with https://www.lucidscientific.com/ include Cell Culture — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.lucidscientific.com/
- Markets served
- United States & Americas
- Keywords
- lucid scientific, resipher, cell culture monitor, oxygen consumption sensor, drug discovery tools
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What are Lucid Scientific's main capabilities for cell culture monitoring?
- Lucid Scientific's RESIPHER system uses patented optical oxygen sensors 10 times smaller and more sensitive than competitors, fitting standard 96-well plates to measure oxygen consumption in real-time for up to four weeks.
- What is the regulatory status of Lucid Scientific's products?
- RESIPHER features calibrated, sterilized lids designed for cell culture experiments, positioning Lucid Scientific as a medical device manufacturer, though specific certifications like FDA clearance are not detailed in available sources.
- Where does Lucid Scientific operate and manufacture?
- Lucid Scientific is headquartered in Atlanta, Georgia, USA, at 311 Ferst Drive NW, with manufacturing focused on expanding production of RESIPHER systems.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
